Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease

References

• Watts PJ, Illum L. Colonic drug delivery. Drug Dev Ind Pharm 1997;23:893–913.
   Web of Science ®Google Scholar
• Kinget R, Kalala W, Vervoort L, van den Mooter G. Colonic drug targeting. J Drug Target 1998;6:129–149.
   PubMed Web of Science ®Google Scholar
• Qi ML, Wu DZ. Design and in vivo evaluation of colonic drug delivery systems. Chinese J Clin Pharm 2000;16:150–154.
   Google Scholar
• Sinha VR, Kumria R. Polysaccharides in colon-specific drug delivery. Int J Pharm 2001;224:19–38.
   PubMed Web of Science ®Google Scholar
• Gang C, Feng A, Mei-Juan Z, Jin S, Xiu-Hua H, Yun-Xia H. Time and pH dependent colon specific drug delivery for orally administered diclofenac sodium and 5 aminosalicylic acid. World J Gastroenterol 2004;10:1769–1774.
   PubMed Web of Science ®Google Scholar
• Patel M, Shah T, Amin A. Therapeutic opportunities in colon-specific drug-delivery systems. Crit Rev Ther Drug Carrier Syst 2007;24:147–202.
   PubMed Web of Science ®Google Scholar
• Patel MM. Cutting-edge technologies in colon-targeted drug delivery systems. Expert Opin Drug Deliv 2011;8:1247–1258.
   PubMed Web of Science ®Google Scholar
• Patel MM, Shah TJ, Amin AF, Shah NN. Design, development and optimization of a novel time and pH-dependent colon targeted drug delivery system. Pharm Dev Technol 2009;14:62–69.
   PubMed Web of Science ®Google Scholar
• Dejaco C, Haas T, Kirchgatterer A, Miehsler W, Wensl H, Knoflach P, Petritisch W, Vogelsang H, Reinisch W, Tilg H. Aminosalicylates and steroids in the treatment of chronic inflammatopry bowel dieases-consensus paper of the working party for chronic inflammatory bowel diseases of the OGGH. Z Gastroeneterol 2006;44:525–538.
   PubMed Web of Science ®Google Scholar
• Siew LF, Man SM, Newton JM, Basit AW. Amylose formulations for drug delivery to the colon: a comparison of two fermentation models to assess colonic targeting performance in vitro. Int J Pharm 2004;273:129–134.
   PubMed Web of Science ®Google Scholar
• Hu Z, Mawatari S, Shimokawa T, Kimura G, Yoshikawa Y, Shibata N, Takada K. Colon delivery efficiencies of intestinal pressure-controlled colon-deliver capsules prepared by a coating machine in human subjects. J Pharm Pharmacol 2001;52:1187–1193.
   Web of Science ®Google Scholar
• Zerna ML, Matteo L, Sangalli C, Sangalli M. Oral pulsatile drug delivery systems. Exp Opin Drug Deliv 2005;2:855–871.
   PubMedGoogle Scholar
• Zerna ML, Matteo L, Sangalli C, Sangalli M. Time-controlled oral delivery systems for colon targeting. Exp Opin Drug Deliv 2006;3:583–597.
   PubMedGoogle Scholar
• Schellekens RC, Stellaard F, Mitrovic D, Stuurman FE, Kosterink JG, Frijlink HW. Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings. J Control Release 2008;132:91–98.
   PubMed Web of Science ®Google Scholar
• Press AG, Hauptmann IA, Hauptmann L, Fuchs B, Fuchs M, Ewe K et al. Gastrointestinal pH profiles in patients with inflammatory bowel disease. Aliment Pharmacol Ther 1998;12:673–678.
   PubMed Web of Science ®Google Scholar
• Karanjit K, Kwonho K. Studies of chitosan/organic acid/Eudragit® RS/RL-coated system for colonic delivery. Int J Pharm 2009;366:140–148.
   PubMedGoogle Scholar
• Wilding IR. A scintigraphic study to evaluate what happens to Pentasa and Asacol in the human gut. Pract Gastroenterol 1999;23:1–9.
   Google Scholar
• Sciarretta G, Furno A, Mazzoni M, Ferrieri A, Malaguti P. Scintigraphic study of gastrointestinal transit and disintegration sites of mesalazine tablets labeled with technetium-99m. Scand J Gastroenterol 1993;28:783–785.
   PubMed Web of Science ®Google Scholar
• Basit AW. Advances in colonic drug delivery. Drugs 2005;65:1991–2007.
   PubMed Web of Science ®Google Scholar
• Sinha A, Ball D, Connor AL, Nightingale J, Wilding IR. Intestinal performance of two mesalamine formulations in patients with active ulcerative colitis as assessed by gamma scintigraphy. Pract Gastroenterol 2003;27:56–69.
   Google Scholar
• Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625–1629.
   PubMed Web of Science ®Google Scholar
• Davis SS, Robertson C, Wilding IR. Gastrointestinal transit of a multiparticulate tablet formulation in patients with active ulcerative colitis. Int J Pharm 1991;68:199–204.
   Web of Science ®Google Scholar
• Friend DR. New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Deliv Rev 2005;57:247–265.
   PubMed Web of Science ®Google Scholar
• Katsuma M, Watanabe S, Kawai H, Takemura S, Masuda Y, Fukui M. Studies on lactulose formulations for colon-specific drug delivery. Int J Pharm 2002;249:33–43.
   PubMed Web of Science ®Google Scholar
• Quinteros DA, Rigo VR, Kairuz AF, Olivera ME, Manzo RH, Allemandi DA. Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs. Eur J Pharm Sci 2008;33:72–79.
   PubMed Web of Science ®Google Scholar
• Kshirsagar SJ, Bhalekar MR, Pawar RP. In vitro drug release and in vivo human X-ray studies of ileo-cecal targeting budesonide fast disintegrating tablet. Drug Dev Ind Pharm 2009;35:788–795.
   PubMed Web of Science ®Google Scholar
• Gupta VK, Beckert TE, Price JC. A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. Int J Pharm 2001;213:83–91.
   PubMed Web of Science ®Google Scholar
• Akhgari A, Sadeghi F, Garekani HA. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets. Int J Pharm 2006;320:137–142.
   PubMed Web of Science ®Google Scholar
• Rowe RC et al. eds. (2006). Handbook of Pharmaceutical Excipients. Pharmaceutical Press and American Pharmaceutical Association: London and USA, 553–560.
   Google Scholar
• Cole ET, Scott RA, Connor AL, Wilding IR, Petereit HU, Schminke C et al. Enteric coated HPMC capsules designed to achieve intestinal targeting. Int J Pharm 2002;231:83–95.
   PubMed Web of Science ®Google Scholar
• Ashford M, Fell JT, Attwood D, Woodhead PJ. An in vitro investigation into the suitability of pH-dependent polymers for colonic targeting. Int J Pharm 1993;91:241–245.
   Web of Science ®Google Scholar
• Khan MZ, Prebeg Z, Kurjakovic N. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation of drug release using Eudragit L100-55 and Eudragit S100 combinations. J Control Release 1999;58:215–222.
   PubMed Web of Science ®Google Scholar
• Khan MZ, Stedul HP, Kurjakovic N. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations. Drug Dev Ind Pharm 2000;26:549–554.
   PubMed Web of Science ®Google Scholar
• Patel MM, Patel SL, Bhadani MN, Shah TJ, Amin AF. A synchronous colon-specific drug delivery system for orally administered mesalamine. Acta Pharm Sci 2009;51:251–260.
   Google Scholar
• http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html. Accessed on 15 August 2009
   Google Scholar
• Mathews BR. Regulatory aspects of stability testing in Europe. Drug Dev Ind Pharm 1999;25:831–856.
   PubMed Web of Science ®Google Scholar
• Krishnaiah YS, Bhaskar Reddy PR, Satyanarayana V, Karthikeyan RS. Studies on the development of oral colon targeted drug delivery systems for metronidazole in the treatment of amoebiasis. Int J Pharm 2002;236:43–55.
   PubMed Web of Science ®Google Scholar
• Shah VP. (2005). The role of dissolution testing in the regulation of pharmaceuticals: The FDA perspective. In: Dressman J, Kramer J, eds. Pharmaceutical Dissolution Testing. New York: Taylor and Francis Group, 81–96
   Google Scholar
• Banker GS, Anderson RN. (1987). Tablets. In: Lachman L, Lieberman HA, Kanig JL, eds. The Theory and Practice of Industrial Pharmacy. Bombay: Varghese Publishing House, 293–345.
   Google Scholar
• Murthy KS. A comparative evaluation of aqueous enteric polymers in capsule coating. Pharm Technol 1986;10:36–46.
   Google Scholar
• Plaizier-Vercammen J, Van Molle M, Steppe K, Cherrette I. Enteric coating properties of Eudragit®, Aquateric® and cellulose acetate trimellitate applied to capsules. Eur J Pharm Biopharm 1986;38:145–149.
   Google Scholar
• Tozaki H, Komoike J, Tada C, Maruyama T, Terabe A, Suzuki T et al. Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. J Pharm Sci 1997;86:1016–1021.
   PubMed Web of Science ®Google Scholar
• Pye G, Evans DF, Ledingham S, Hardcastle JD. Gastrointestinal intraluminal pH in normal subjects and those with colorectal adenoma or carcinoma. Gut 1990;31:1355–1357.
   PubMed Web of Science ®Google Scholar
• Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988;29:1035–1041.
   PubMed Web of Science ®Google Scholar
• Fallingborg J, Christensen LA, Jacobsen BA, Rasmussen SN. Very low intraluminal colonic pH in patients with active ulcerative colitis. Dig Dis Sci 1993;38:1989–1993.
   PubMed Web of Science ®Google Scholar
• Abrahamsson B, Alpsten M, Jonsson UE, Lundberg PJ, Sandberg A, Sundgren M, Svenheden A, Tölli J. Gastrointestinal transit of a multipleunit formulation (metoprolol CR/ZOK) and a nondisintegrating tablet with emphasis on colon. Int J Pharm 1996;140:229–235.
   Web of Science ®Google Scholar
• Leopold CS, Eikeler D. Basic coating polymers for the colon-specific drug delivery in inflammatory bowel disease. Drug Dev Ind Pharm 2000;26:1239–1246.
   PubMed Web of Science ®Google Scholar
• Gidenne T, Lebs F. (2006). Feeding behavior in rabbits. In: Bels V, ed Feeding in Domestic Vertebrates: From Structure to Behavior. Oxfordshire: CABI Publishing, 179–194.
   Google Scholar
• Ghosh MN. (2008). Fundamentals of experimental pharmacology. Kolkata: SK Ghosh and others, 176–183.
   Google Scholar
• Patel MM, Amin AF. Design and optimization of colon-targeted system of theophylline for chronotherapy of nocturnal asthma. J Pharm Sci 2011;100:1760–1772.
   PubMed Web of Science ®Google Scholar
• Patel MM, Amin AF. Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer. Drug Deliv 2011;18:281–293.
   PubMed Web of Science ®Google Scholar
• Patel MM, Amin AF. Process, optimization and characterization of mebeverine hydrochloride loaded guar gum microspheres for irritable bowel syndrome. Carbohydr Polym 2011;86:536–545.
   Web of Science ®Google Scholar